Aprea Therapeutics, Inc.

Aprea Therapeutics, Inc. price (APRE)

$0.00
USD 0.00(0.00%)
1 month
Volume
Market Cap
52 Week
High
Low
Prev. Close

About Aprea Therapeutics, Inc.

Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded in 2002 and is headquartered in Boston, MA.

Sector
Commercial Services
CEO
Christian S. Schade
Industry
Miscellaneous Commercial Services
Exchange
NASDAQ

Top Stories

Coming soon.